Showing results (241-250 of 397) with videos related to

Sort By:
Pageof 40
Gynecologic Oncology|November 7, 2000
Treatment of relapsed carcinoma of the ovary with single-agent paclitaxel following exposure to paclitaxel and platinum employed as initial therapyK M Zanotti, J L Belinson, A W Kennedy, et al.
Gynecologic Oncology|August 1, 1996
Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicityE Connelly, M Markman, A Kennedy, et al.
Gynecologic Oncology|March 27, 2001
Phase I trial of ifosfamide and 24-h infusional paclitaxel in pelvic malignancies: a Gynecologic Oncology Group studyM Markman, D Spriggs, R A Burger, et al.
American Journal of Hospital Pharmacy|May 1, 1989
Stability of floxuridine and leucovorin calcium admixtures for intraperitoneal administrationJ A Smith, A Morris, M E Duafala, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
High-dose cisplatin with diethyldithiocarbamate (DDTC) rescue therapy: preliminary pharmacologic observationsM W DeGregorio, D R Gandara, W M Holleran, et al.
Gynecologic Oncology|July 1, 1996
Tamoxifen in platinum-refractory ovarian cancer: a Gynecologic Oncology Group Ancillary ReportM Markman, K A Iseminger, K D Hatch, et al.
Journal of Chromatography|May 3, 1991
High-performance liquid chromatographic method for the simultaneous measurement of floxuridine and fluorouracil in human body fluidsJ A Smith-Rogers, W P Tong, M E Duafala, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
A phase II trial of PALA + dipyridamole in patients with advanced soft-tissue sarcomaE S Casper, J Baselga, T B Smart, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 17, 2004
Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology GroupD S Alberts, C Jiang, P Y Liu, et al.
Acta Medica Austriaca|January 1, 1989
Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience)M Markman, B Reichman, T Hakes, et al.
Pageof 40